Skip to main content
. Author manuscript; available in PMC: 2015 Aug 15.
Published in final edited form as: Clin Cancer Res. 2014 Jun 9;20(16):4176–4185. doi: 10.1158/1078-0432.CCR-13-2024

Table 1.

Complete Listing of Data Contributed by Group and Protocol:

Protocol Type of Trial Protocol Tx Setting N
ECOG-1202 Phase II Chemotherapy First Line 10
ECOG-1298 Phase II Chemotherapy First Line 32
ECOG-2297 Phase III Chemotherapy First Line 321
ECOG-3292 Phase II Chemo/Immunoth. First Line 24
ECOG-3296 Phase II Chemotherapy First Line 36
NCCTG-0043 Phase II Chemo/Biologic First Line 48
NCCTG-014C Randomized Phase II Biologic First Line 42
NCCTG-014C Randomized Phase II Chemo/Biologic First Line 39
NCCTG-034A Phase II Chemo/Biologic First Line 79
NCCTG-894352 Phase III Chemotherapy Either 94
NCCTG-924352 Phase II Chemotherapy Either 46
NCCTG-964351 Phase II Chemotherapy First Line 13
NCCTG-984351 Phase II Chemotherapy Either 58
NCCTG-9942 Phase II Concurrent Chemo/RT First Line 46
RTOG-0020 Randomized Phase II Concurrent Chemo/RT First Line 91
RTOG-0411 Phase II Chemo/biologic/RT First Line 82
RTOG-9102 Phase III Concurrent Chemo/RT First Line 27
RTOG-9209 Phase II Concurrent Chemo/RT First Line 50
RTOG-9812 Phase II Concurrent Chemo/RT Either 109
SWOG-0107 Phase II Chemotherapy First Line 60
SWOG-0205 Phase III Chemotherapy First Line 347
SWOG-0205 Phase III Chemo/Biologic First Line 348
SWOG-8916 Phase II Chemotherapy First Line 25
SWOG-8933 Phase II Chemotherapy First Line 35
SWOG-9100 Phase II Chemo/Potentiator First Line 26
SWOG-9135 Phase II Chemotherapy First Line 39
SWOG-9413 Phase II Chemo/Immunoth. First Line 55
SWOG-9629 Phase II Chemo/Potentiator First Line 58
SWOG-9629 Phase II Chemo/Potentiator Second Line or More 48
SWOG-9924 Phase II Biologic First Line 53